Piracetam (2-Oxo-1-pyrrolidineacetamide) Research Standard
Piracetam (2-oxo-1-pyrrolidineacetamide) is a cyclic derivative of the endogenous neurotransmitter GABA and serves as the foundational parent compound of the racetam class. As the archetype for this series, it has been a cornerstone of neuropharmacological research since 1964. Its defining characteristic in scientific literature is its complex, unresolved mechanism of action, which continues to drive investigations into membrane biophysics, neuronal excitability, and mitochondrial bioenergetics. Because it acts as an all-encompassing scaffold for the entire racetam series, it remains a requisite reference standard for structure-activity relationship (SAR) studies.
Technical Specifications
| Property | Specification |
|---|---|
| Product Name | Piracetam |
| IUPAC Name | 2-oxo-1-pyrrolidineacetamide |
| Chemical Formula | C₆H₁₀N₂O₂ |
| Molecular Weight | 142.16 g/mol |
| CAS Number | 7491-74-9 |
| Chemical Class | Pyrrolidinone (Racetam class parent) |
| Physical Appearance | White crystalline powder |
| Assay Purity | Refer to the batch-specific Certificate of Analysis (COA) supplied for the lot received |
Mechanism of Action & Research Context
Piracetam’s pharmacology remains a subject of active study. It does not function as a direct agonist or antagonist at any single identified receptor, which distinguishes it from more targeted pharmaceutical agents.
-
Membrane Biophysics: Research investigates the compound’s interaction with the phospholipid bilayer, hypothesizing that it modulates neuronal membrane fluidity, which may indirectly influence receptor protein function and cellular signaling efficiency.
-
AMPA Receptor Modulation: Studies have explored the allosteric modulation of AMPA-type glutamate receptors, proposing that piracetam may influence receptor density or sensitivity in specific neuronal populations.
-
Mitochondrial Bioenergetics: Investigations into mitochondrial function suggest that piracetam may influence oxygen and glucose consumption pathways, providing a stable model for studying cellular energy metabolism under stress.
Research Applications
Piracetam is utilized primarily as a standardized reference compound in comparative neuropharmacology and biophysical studies.
Primary fields of in vitro laboratory investigation include:
-
Membrane Biophysics: Mapping the interactions between pyrrolidinone derivatives and phospholipid model systems to understand how chemical structure influences bilayer dynamics.
-
AMPA Receptor Signaling: Using piracetam as a comparative tool in glutamate receptor modulation assays.
-
Mitochondrial Respirometry: Measuring bioenergetic shifts and ATP production efficiency in cellular cultures exposed to varying concentrations of the parent racetam scaffold.
-
Structure–Activity Relationship (SAR) Research: Serving as the definitive control molecule when evaluating the binding affinity or signaling modulation of newer, higher-potency racetam derivatives.
Storage & Handling Guidelines
Store at controlled room temperature. Keep tightly closed.
Storage guidance is a house recommendation. Analytical documentation is per-lot release testing.
References
-
Giurgea C. (1973) “The ‘nootropic’ approach to the pharmacology of the integrative activity of the brain.” Cond. Reflex. 8(2): 108–115.
-
Malykh AG, Sadaie MR. (2010) “Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders.” Drugs. 70(3): 287–312.
Related Research Compounds
Research Use Disclaimer
Research Use Only Disclaimer: This product is developed and distributed strictly as a Research Use Only (RUO) laboratory reference chemical intended exclusively for non-clinical analytical and scientific investigation. It is not an FDA-approved drug, medical treatment, dietary supplement, or food ingredient, and is strictly prohibited for human or animal consumption. Kimera Chems supplies this research material solely to qualified institutions and professional investigators for authorized laboratory research.
